BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3
46 results:

  • 1. Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors.
    Thiis-Evensen E; Kjellman M; Knigge U; Gronbaek H; Schalin-Jäntti C; Welin S; Sorbye H; Del Pilar Schneider M; Belusa R;
    J Neuroendocrinol; 2022 Jul; 34(7):e13176. PubMed ID: 35829662
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
    Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
    J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Primary Rhabdomyosarcoma of the breast in a 16-Year-Old Girl].
    Maekawa M; Kittaka N; Hatano T; Tokui R; Kusama H; Matsui S; Nishio M; Fujisawa F; Honma K; Nakayama T; Tamaki Y
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2030-2032. PubMed ID: 35045483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential Diagnosis in Hypophysitis: First Report on a Spindle Cell Rhabdomyosarcoma of the Pituitary Gland.
    Ahmeti H; Jüttner E; Röcken C; Jansen O; Laudes M; Synowitz M
    J Neurol Surg A Cent Eur Neurosurg; 2023 May; 84(3):295-299. PubMed ID: 34781400
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal cancer.
    Sui Y; Li X; Oh S; Zhang B; Freeman WM; Shin S; Janknecht R
    Sci Rep; 2020 May; 10(1):8710. PubMed ID: 32457453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common breast cancer Markers.
    Forse CL; Pinnaduwage D; Bull SB; Mulligan AM; Andrulis IL
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):231-237. PubMed ID: 29553968
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of breast cancer.
    Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H
    Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.
    Shurell E; Olcese C; Patil S; McCormick B; Van Zee KJ; Pilewskie ML
    Cancer; 2018 Jan; 124(1):46-54. PubMed ID: 28960259
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Repression of ESR1 transcription by myod potentiates letrozole-resistance in ERα-positive breast cancer cells.
    Zhang Q; Liu XY; Li S; Zhao Z; Li J; Cui MK; Wang EH
    Biochem Biophys Res Commun; 2017 Oct; 492(3):425-433. PubMed ID: 28842253
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Alternative Polyadenylation in Triple-Negative breast Tumors Allows NRAS and c-JUN to Bypass pumILIO Posttranscriptional Regulation.
    Miles WO; Lembo A; Volorio A; Brachtel E; Tian B; Sgroi D; Provero P; Dyson N
    Cancer Res; 2016 Dec; 76(24):7231-7241. PubMed ID: 27758885
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A COMPARATIVE ANALYSIS OF METHYLATION STATUS OF TUMOR SUPPRESSOR GENES IN PAIRED BIOPSY AND SERUM SAMPLES FROM CERVICAL cancer PATIENTS AMONG NORTH INDIAN POPULATION.
    Jha AK; Sharma V; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J
    Genetika; 2016 Feb; 52(2):255-9. PubMed ID: 27215041
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.
    Chen D; Goswami CP; Burnett RM; Anjanappa M; Bhat-Nakshatri P; Muller W; Nakshatri H
    Cancer Res; 2014 Aug; 74(16):4270-81. PubMed ID: 24980554
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Structure activity relationships of peptidic analogs of myod for the development of Id1 inhibitors as antiproliferative agents.
    Hsiao YC; Yang DL; Hung HL; Lung FD
    J Pept Sci; 2013 Nov; 19(11):676-83. PubMed ID: 24123584
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Rhabdomyosarcoma of the breast: a clinicopathologic study and review of the literature.
    Li DL; Zhou RJ; Yang WT; Wang J; Yao XH; Cheng YF; Shi DR
    Chin Med J (Engl); 2012 Jul; 125(14):2618-22. PubMed ID: 22882949
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.
    Lirk P; Berger R; Hollmann MW; Fiegl H
    Br J Anaesth; 2012 Aug; 109(2):200-7. PubMed ID: 22542536
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.
    Buhmeida A; Merdad A; Al-Maghrabi J; Al-Thobaiti F; Ata M; Bugis A; Syrjänen K; Abuzenadah A; Chaudhary A; Gari M; Al-Qahtani M; Dallol A
    Anticancer Res; 2011 Sep; 31(9):2975-81. PubMed ID: 21868547
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Involvement of myod and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Jin W; Liu Y; Chen L; Zhu H; Di GH; Ling H; Wu J; Shao ZM
    Breast Cancer Res Treat; 2011 Feb; 125(3):699-713. PubMed ID: 20364308
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Affinity of synthetic peptide fragments of myod for Id1 protein and their biological effects in several cancer cells.
    Chen CH; Kuo SC; Huang LJ; Hsu MH; Lung FD
    J Pept Sci; 2010 May; 16(5):231-41. PubMed ID: 20235117
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
    Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
    Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.